Table 1.

Perioperative data (Varese, 2014)

	Surgeon A	Surgeon B
Cases (n)	48	52
Median age (yrs, range)	71 (50–86)	68 (51–84)
Median Adenoma volume (TRUS, ml, range)	61 (30–130)	60 (30–105)
Median PSA (ng/dl, range)	6.32 (1.2–37.1)	5.98 (0.7–23.6)
I-PSS moderate/high	24/ 17 (7 n.v.)	25/ 17 (10 n.v.)
Median Surgical time (min, range)	92 (34–160)	86 (40–127)
Median Laser emission time (min, range)	28 (16–58,44)	24 (19–37,16)
Median Total energy delivered (J, range)	165,650 (84,820–386,920)	163,445 (87,540–358,327)
600 μm fiber use (no. cases)	18	11
800 μm fiber use (no. cases)	30	41
Intraoperative complications	•1 Bladder perforation	•1 Bladder perforation
	•1 Intraoperative bleeding, with necessity to delay morcellation
Contemporary procedures	•3 bladder ELT	•2 URS
		•5 bladder ELT
Reoperations	•1 Morcellation on first postoperative day	•1 Hemostatic TUR (first postoperative day)
	•1 TURP for chronic retention (6 months later)	•1 Morcellation of a residual fragment (1 month later)
		•1 Urethrotomy for bulbar urethral stenosis (9 months later)